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Abstract
The C1ORF112 gene initially drew attention when it was found to be strongly co‐expressed with several genes previously 
associated with cancer and implicated in DNA repair and cell cycle regulation, such as RAD51 and the BRCA genes. The 
molecular functions of C1ORF112 remain poorly understood, yet several studies have uncovered clues as to its potential 
functions. Here, we review the current knowledge on C1ORF112 biology, its evolutionary history, possible functions, 
and its potential relevance to cancer. C1ORF112 is conserved throughout eukaryotes, from plants to humans, and is very 
highly conserved in primates. Protein models suggest that C1ORF112 is an alpha-helical protein. Interestingly, homozygous 
knockout mice are not viable, suggesting an essential role for C1ORF112 in mammalian development. Gene expression data 
show that, among human tissues, C1ORF112 is highly expressed in the testes and overexpressed in various cancers when 
compared to healthy tissues. C1ORF112 has also been shown to have altered levels of expression in some tumours with 
mutant TP53. Recent screens associate C1ORF112 with DNA replication and reveal possible links to DNA damage repair 
pathways, including the Fanconi anaemia pathway and homologous recombination. These insights provide important avenues 
for future research in our efforts to understand the functions and potential disease relevance of C1ORF112.
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Introduction
Genomic and proteomic technologies have facilitated the 
rapid generation and analysis of large volumes of data [1, 2]. 
In turn, this has enabled researchers to discover and charac-
terise novel genes to further our understanding of the role 
of cellular networks and pathways within biological and 
disease processes. In one such high‐throughput analysis, 
van Dam et al. (2012) identified the mouse BC055324 gene 
[3], whose human ortholog is C1ORF112, as being strongly 
co‐expressed with genes previously associated with cancer 
in the literature, like RAD51 and CCDC6. C1ORF112 is 
also co-expressed with many genes in the BRCA–Fanconi 
anaemia-related DNA damage response pathway, including 
BRCA1, BRCA2, FANCD2, and FANCI [3]. Defects in this 
pathway are associated with increased cancer risk [4].
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The breast cancer susceptibility proteins BRCA1 (also 
known as FANCS), BRCA2 (FANCD1), and RAD51 
(FANCR) and its paralogs, including XRCC2 (FANCU) and 
XRCC3, all serve a function in homologous recombination 
repair (HRR). HRR is a critical DNA repair process which 
operates not only in addressing directly occurring DNA dou-
ble‐strand breaks, but also in the repair of broken and stalled 
DNA replication forks [5]. FANCD2 and FANCI are critical 
proteins that are mono‐ubiquitylated as part of the activation 
process within the Fanconi anaemia (FA) pathway, which is 
required for the repair of inter‐strand crosslinks (ICLs) [6]. 
Individuals with defects in the FA pathway are highly can-
cer-prone and are particularly susceptible to acute myeloid 
leukaemia and head and neck squamous cell carcinoma [4]. 
FANCD2 and FANCI lie at the centre of the FA‐BRCA path-
way and are mono‐ubiquitylated by the upstream FA core 
complex (comprising nine FA or FA‐associated proteins). 
Downstream of the mono‐ubiquitylation of FANCD2 and 
FANCI are the FA proteins that function directly in DNA 
repair, including HRR. ICLs are a specific form of DNA 
damage that block transcription and DNA replication, and 
require removal by several DNA repair processes, including 
translesion DNA synthesis and HRR, which are in turn coor-
dinated by the FA pathway. Whilst repair by HRR is largely 
error‐free when it, or the FA pathway itself, is defective; 
DNA double‐strand breaks and broken replication forks may 
be erroneously repaired by non‐homologous end joining 
(NHEJ) [7]. In Arabidopsis thaliana, a role for C1ORF112 
has been implicated in all these DNA damage response pro-
cesses [8]. Earlier studies hinted of a possible association 
of C1ORF112 with cancer [9, 10]. For example, in a study 
of bladder cancer progression, the genomic and proteomic 
profiles in association with TP53 show that C1ORF112 has 
a gene expression fold change corresponding to an increased 
expression with tumours having mutant TP53, an oncogene 
involved in driving various cancers [9]. Another study 
concerning gene expression in response to regulation by a 
progesterone hormone‐dependent breast cancer transfected 
with progesterone receptors exhibited a down‐regulation of 
C1ORF112 expression, suggesting that C1ORF112 might 
be a target for progesterone regulation [10].
Considering this background, we suggest that C1ORF112 
could be a gene of significant biological and clinical interest. 
Here, we review what we know about C1ORF112, discuss 
its potential functions, identify possible cellular pathways in 
which it may operate, and ascribe possible roles in diseases 
such as cancer.
Sequence characteristics of C1ORF112
Chromosome 1 Open Reading Frame 112 (C1ORF112) 
codes for nine transcripts. The chromosomal locus for 
C1ORF112 is 1q24.2. It can also be identified as FLJ10706 
(HGNC) or ENSG00000000460 (Ensembl). C1ORF112 is 
encoded in a 5′ → 3′ forward direction. Of nine transcripts, 
five are translated into proteins, while four undergo non-
sense‐mediated decay. The first two transcripts are 853 
amino acids in length and comprise 4355 bps containing 
24 exons and 4011 bps containing 25 exons, respectively 
[11]. There are no domain motifs currently attributed to 
this protein, as it is currently classified under the domain of 
unknown function DUF4487 [12]. Proteins in this domain 
family have a conserved WCF tripeptide sequence (Fig. 1) 
which may be of functional relevance [12].
Fig. 1  C1ORF112 alignment in five selected species. The protein 
alignment was downloaded from the OMA genome browser [21] 
showing a high level of conservation among vertebrates. We used 
BLOSUM62 (Blocks Substitution Matrix) to identify similarities 
arising between the species [22]. The sequence in blue represents a 
threshold of 62% identity, and the red positions represent the WCF 
conserved amino acids
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Evolutionary history of C1ORF112
We reconstructed the evolutionary history of C1ORF112 
using 67 orthologous sequences from representative species 
of all major groups of Eukaryotes. The orthologues were 
sought within the Orthologous Matrix project (OMA) [13], 
using the Pfam entry [14], and entry DUF4487 and also 
through local BLAST searches [15, 16]. Protein sequences 
were aligned using the L‐INS‐I strategy from MAFFT v747 
[17]. We inferred the gene tree of C1ORF112 using the max-
imum-likelihood program IQ‐TREE multicore version 1.6. 
for Linux [18]. The best model of substitution (JTT + F + G4) 
was selected using ultrafast bootstrap replicates [19]. iTOL 
v5.5.1 [20] was used for gene tree visualisation and the 
images were obtained from PhyloPic (http://phylo pic.org/). 
The multiple sequence alignments show high levels of con-
servation within the gene sequences. As stated earlier, there 
is a conserved WCF tripeptide in most of the species, and 
this is usually preceded by the amino acid LAMDA, fol-
lowed by the amino acids LARY, predominantly in verte-
brate sequences. Sequence alignment of model organisms 
in which the gene is present indicates that the WCF amino 
consistently present (Fig. 1).
We found that C1ORF112 may have originated in the 
ancestor of all Eukaryotes (Fig.  2). The phylogenetic 
relationship between the main groups (e.g., vertebrates, 
Fig. 2  C1ORF112 gene tree. The phylogenetic relationship arising between the main groups of Eukaryota and different species are in general 
well conserved from plants to humans, with a bootstrap support > 70%
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protostomia, viridiplantae, and fungi), as well as between 
species are, in general, well conserved from plants to 
humans. However, notable exceptions are found; for exam-
ple, Drosophila falls outside the Metazoa and the mouse falls 
into the sister group to placental mammals (Fig. 2). In addi-
tion, most organisms containing a homologue of C1ORF112 
are multi‐cellular organisms with notable exceptions such 
as Acanthamoeba castellanii, Capsaspora spp, and Cre-
olimax fragrantissima. C1ORF112 homologs are found in 
plants, but appear to be mostly absent in fungi, suggestive 
of a gene loss event, exceptions being the early diverging 
fungal group Chytridiomycota and the Mucoromycota. Sen-
sitive HMM–HMM searches at the HHpred server [23] were 
used to further query model organisms in which homologs 
appear to be absent. These searches confirmed the absence 
of C1ORF112 proteins in S. cerevisiae and C. elegans, but 
revealed CG13742 to be the likely D. melanogaster homolog 
(Table 1). However, CG13742 does not possess the WCF 
tripeptide, which is present in other model organisms, and 
the sequence identity is also quite low when compared to 
the sequences of other model organisms (Table 1). Overall, 
C1ORF112 is evolutionarily well‐conserved across verte-
brates, with homologues also present in some invertebrates, 
plants, and single‐celled microorganisms.
Structure of the C1ORF112 protein
The Pfam entry corresponding to C1ORF112 and DUF4487 
records no structures for family members. Indeed, BLAST 
searches of the Protein Data Bank [15, 24] yield no sig-
nificant hits, demonstrating that no close homologues of 
C1ORF112 have yet been structurally characterised. Nev-
ertheless, the sensitive HMM–HMM comparison method 
HHpred [23] revealed significant matches to proteins with 
repetitive alpha helix‐rich structures. The strongest match, 
with a probability of 87% (albeit with a sequence identity 
of only 8%), was to the beta subunit of the human importin 
which contains HEAT repeats (e.g., PDB code 1qgr [25]). 
Other proteins containing HEAT repeats, such as microtu-
bule‐ binding TOG domains (e.g., 2 of 3 [26]), PTPA protein 
phosphatase activator (e.g., 4 lac [27]), and the yeast cyto-
plasmic export protein 1 (e.g., 3vwa [28]) also achieved sig-
nificant scores.
HEAT repeats, and the related ARM repeats, form part 
of a large superfamily of repetitive structures in which the 
repeating unit, around 50 residues long, contains two or 
three helices [29]. Despite their involvement in a wide vari-
ety of cellular processes, they share a molecular mechanism 
in which the repeats trace out a curved 3D structure on the 
inner side in which residues from multiple adjacent repeats 
combine to form protein–protein interaction sites. Using 
the HHpred alignment between C1ORF112 and the impor-
tin beta subunit, a molecular model of residues 304‐763 
of C1ORF112 was constructed using the Swiss Model 
server [30]. The low-sequence identity and high evolution-
ary distance arising between C1ORF112 and the importin 
beta subunit ensure that the model quality will be limited. 
Nevertheless, the ConSurf server [31], when used for map-
ping sequence conservation in the C1ORF122 family onto 
the approximate model, revealed that the inner side of the 
curved structure is significantly more conserved than the 
outer surface (Fig. 3). This provides independent support 
for the expectation that the inner surface harbours inter-
faces for binding to its interaction partners. The model also 
illustrates the structural context of the aforementioned WCF 
motif: the Trp residues form part of the hydrophobic core, 
whereas the Phe residue lies on the surface where it is likely 
to contribute to interactions with a partner protein. Interest-
ingly, the model of the central portion of C1ORF112 reveals 
two significant conserved surface patches, one containing 
the WCF motif and the other located towards the end of 
the modelled region. These may function as distinct inter-
faces for different sets of interactors, but could also, as in 
the importin beta subunit [32], target distinct regions of the 
same large interactor. We also validated the above results by 
modelling C1ORF112 in another well‐known server called 
I‐TASSER (Zhang 2008), one which uses threading and 
ab‐initio methods to predict the structure and found similar 
folding patterns.
Table 1  C1ORF112 amino acid sequence similarity between humans and selected biomedical model organisms
Species Amino acid % similarity with Homo sapi-
ens C1ORF112 (Gene ID: 55732; Ensembl: 
ENSG00000000460)
Mus musculus (Entrez Gene ID: 381306; Ensembl: ENSMUSG00000041406) 67.7%
Rattus norvegicus (Entrez Gene ID: 498265; Ensembl: ENSRNOG00000059276) 69.0%
Danio rerio (Entrez Gene ID: 553598; Ensembl: ENSDARG00000042120) 42.8%
Drosophila melanogaster (Entrez Gene ID: 35916; FlyBase: FBgn0033372) 11.8%
Caenorhabditis elegans No homologs found
Saccharomyces cerevisiae No homologs found
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Putative functions of C1ORF112
Early studies linking C1ORF112 to cancer
The exact functions of C1ORF112 in humans and other 
vertebrates are currently unknown. However, there have 
been several studies that afford insights into its potential 
actions. Leo et al. (2005) studied the gene regulation profile 
of hormone‐independent breast cancer cells which had been 
transfected with the progesterone receptor (PR), but were 
otherwise negative for the oestrogen receptor (ER‐). The 
results of this study revealed a threefold down‐regulation of 
C1ORF112 (known at the time as FLJ10706) in the presence 
of PR [10], suggesting that C1ORF112 could be a proges-
terone-regulated gene. Another study [9] focused on under-
standing genomic and proteomic profiles of gelsolin in rela-
tion to TP53 status and bladder cancer progression. These 
showed a twofold down-regulation of C1ORF112, placing it 
in the top 30 differentially expressed genes arising between 
wild‐type presenting TP53 and mutant TP53 cells within 
invasive bladder tumour cells. C1ORF112 was also found to 
have a twofold up‐regulation in desmoid tumours when com-
pared to normal fibroblasts [33]. Another regulator impli-
cated in acting upon C1ORF112 is guanosine‐5′‐triphos-
phate (GTP); a well‐known G‐protein modulator, which was 
shown to effect a > two fold up‐regulation of C1ORF112 
in SH‐SY5Y cells. However, the mode of action and the 
implications of this interaction is yet unknown [34]. Each of 
these independent studies, including the earlier mentioned 
van Dam et al. study [3], indicates that C1ORF112 must 
interact with proteins involved in cell‐cycle progression and 
suggest possible interactions with tumorigenic genes.
Mouse studies suggesting a role for BC055324 in early 
development
Interestingly, knockout mice of the C1ORF112 homo-
logue, BC055324 are embryonically lethal (https ://www.
mouse pheno type.org/data/genes /MGI:35905 54), suggest-
ing that BC055324 plays an important function, at least 
during early development [35]. Microarray data from the 
Genevestigator database (using the Mouse Genome 430A 
2.0 Array) show that BC055324 is very highly expressed 
in the renal vesicles, mesenchyme, ureteric bud, embry-
onic cells, blastocyst cells, oocytes, and foetal haemopoi-
etic stem cells [36], again strongly suggesting a role in 
early development. Further evidence to support this argu-
ment comes from the effect of deleterious mutations of 
the transcriptional enhancer M1442 in generating signifi-
cant reductions in transcriptional variation in BC055324, 
bringing the gene physically closer to regulatory elements 
which confer transcriptional robustness [37, 38]. As genes 
which play a significant role in development often have 
tightly controlled transcriptional regulators, this is further 
evidence for a role of BC055324 in development which is 
tightly regulated by M1442 (a homolog of human H1442).
While homozygous animals do not survive, heterozy-
gous animals have been phenotyped as part of the Interna-
tional Mouse Phenotyping Consortium [35, 39]. Briefly, 
heterozygous animals have been reported to show an 
increase in lean body mass and circulating cholesterol 
levels, as well as abnormal bone mineralization, possibly 
resulting in decreased bone mineral density (https ://www.
mouse pheno type.org/data/genes /MGI:35905 54). Mouse 
models are available for BC055324 that permit research-
ers to conduct further such studies [35]. Unpublished 
Fig. 3  3D structure of 
C1ORF112. An approximate 
structural model of residues 
304–763 of C1ORF112 based 
on the alignment produced by 
HHpred [23] with importin beta 
subunit (1qkg;). Conservation 
mapping with the ConSurf 
server [31] left (blue indi-
cates high conservation in the 
C1ORF112 family; red indicates 
low conservation) reveals two 
conserved patches, the upper 
containing the conserved WCF 
motif (magenta sticks on the 
right), where the protein is col-
oured blue to red from the N‐ to 
the C‐terminus
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work by Cordeiro, Edogbanya, and de Magalhães et al. 
suggests that the ablation of BC055324 in adult animals 
using conditional knockout mice yields no obvious phe-
notypic differences.
Functional insights from co‐expression and protein 
interactions
As aforementioned, C1ORF112 was initially found to be 
strongly co‐expressed with cancer‐related genes [3]. To 
be more precise, mouse genes significantly co‐expressed 
with a seed list of previously published cancer‐associated 
genes were, based on a “guilt‐by‐association” approach, 
used to identify novel cancer‐associated candidate genes 
[3]. Among the candidate cancer‐associated genes were 
some poorly studied genes, the most statistically signifi-
cant of which was BC055324. The human homolog of 
BC055324 is C1ORF112. Like BC055324, C1ORF112 
is co‐expressed with several genes associated with can-
cer and is strongly co‐expressed with BRCA1 and BRCA2 
genes [3]. In addition, genes that play important roles in 
cell cycle regulation and cancer formation are among the 
most strongly co‐expressed with C1ORF112. Silencing 
C1ORF112 reduces growth of the HeLa cancer cell line 
when compared to control siRNAs [3].
Querying C1ORF112 in STRING [40] reveals sev-
eral text-mining gene associations from van Dam et al. 
(2012), but also strong links via gene co‐expression 
between C1ORF112 and ten proteins. The strongest three 
scores are for ASPM, CENPF, and NCAPG, proteins 
linked in various ways to mitosis. Indeed, when the set 
of C1ORF112 and the ten associated matches are tested 
for statistical enrichment of terms in standard databases 
and ontologies, the cell cycle is the most significant Bio-
logical Process in the Gene Ontology (false discovery 
rate FDR, 4.9e‐07) while, for UniProt [41], mitosis is the 
keyword most strongly linked (FDR, 1.7e‐07). A more 
recent analysis of the expression of stem cell-related 
genes in gastric cancer revealed a co-expression mod-
ule of 16 genes associated with stem cell self-renewal 
and cell proliferation, one of which was C1ORF112 [42]; 
another similar study also found C1ORF112 as part of a 
nine-gene risk model associated with disease outcomes 
in gastric cancer patients [43]. These findings confirm 
that the co‐expression‐based implications of a potential 
involvement of C1ORF112 in cell cycle and cancer hold 
when the large increase in expression data obtained since 
its initial discovery in 2012 are considered.
Furthermore, whether acting as bait or hit interactors, 
various high-throughput affinity capture mass spectrom-
etry (MS) experiments obtained from the BioGRID data-
base [44] reveal 31 physical protein–protein interactions 
for C1ORF112 (https ://thebi ogrid .org/12085 1/summa 
ry/homo‐ sapiens/c1orf112.html). These interactions are 
shown in Fig. 4.
Proteomic studies and functions of C1ORF112 in DNA repair 
and the Fanconi anaemia pathway
Recent proteomic studies on the repair of DNA inter‐strand 
crosslinks (ICL) observed C1ORF112 to be recruited to 
protein complexes at ICL-stalled DNA replication forks in 
Xenopus egg extracts [46]. The stalling of DNA replication 
forks arises due to ICLs recruiting around ninety DNA 
repair and genome maintenance factors. These included 
FA pathway proteins that coordinate the repair of ICLs, 
homologous recombination repair proteins, including 
BRCA1 (FANCS), and BRCA2 (FANCD1), the SLF1/
SLF2 protein complex, and C1ORF112. This strongly indi-
cates that C1ORF112 might serve a role in DNA repair, 
specifically in responses to replication stress brought 
about by DNA damage through ICL [46]. These various 
findings strongly implicate a role for C1ORF112 in DNA 
replication.
A role for C1ORF112 in DNA damage responses is 
further indicated by the observation that C1ORF112 ‐/‐ 
cells exhibit a significant hypersensitivity to mitomycin C 
(MMC), a canonical inducer of ICLs. ICL‐hypersensitiv-
ity is a hallmark of both FA‐ and HRR‐defective cell lines 
and, further, C1ORF112 ‐/‐ cells additionally display other 
FA‐like features (Bell and Jones, manuscript in prepara-
tion). These include MMC-induced chromosomal aberra-
tions, including chromatid abnormalities and radial rear-
rangements, notwithstanding a G2/M cell cycle delay, all of 
which are characteristics of FA‐defective cells [47]. These 
observations indicate a likely role for C1ORF12 within the 
FA pathway itself or in its regulation.
Cells that are defective in HRR, including BRCA1 and 
BRCA2/FANCD1, in addition to other components of the 
downstream FA pathway, are typically hypersensitive to 
DNA damaging agents other than ICLs [48]. These include 
mono‐functional alkylating agents such as methyl methane-
sulphonate (MMS), ethyl methanesulphonate (EMS), and 
methylnitronitrosoguanidine (MNNG), all of which can 
give rise to DNA replication fork stalling and indirect DNA 
double‐strand breaks. C1ORF112 knockout cells exhibit sig-
nificant hypersensitivity to MMS and EMS and express the 
mono-ubiquitylated form of FANCD2, suggesting that, if 
C1ORF112 does function within the FA pathway, it is likely 
to be in the downstream HRR part of the pathway.
Significantly, one recent study, using RPE1‐hTERT Cas9 
TP53 − / − cells to perform genome‐scale CRISPR screens 
against DNA‐damaging agents, found C1ORF112 to be 
important in resistance to DNA‐damaging agents, includ-
ing Cisplatin‐2, Cisplatin‐3, and MNNG [49]. Importantly, 
C1ORF112 very strongly clusters with FA/ICL repair genes 
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within the map constructed for this study [49]. The sensi-
tivity to cisplatin drugs (ICL‐inducing) and MNNG is con-
sistent with the sensitivities of C1ORF112 ‐/‐ and further 
alludes to a functional association of C1ORF112 within the 
FA pathway.
Intriguingly, the pivotal FA pathway protein FANCD2 
has very recently been demonstrated to directly interact 
with ALDH3A2 (Wataru Sakai, Kobe University Japan, 
personal communication), which itself directly interacts 
with C1ORF112 (see Fig. 4). ALDH3A2 is an aldehyde 
dehydrogenase that catalyses the oxidation of medium and 
long-chain aliphatic aldehydes to fatty acids [50]. A major 
function of the FA pathway and FANCD2, specifically, is 
in mediating the DNA damage response to the toxic effects 
of endogenous aldehydes [51]. The interaction with both 
FANCD2 and ALDH3A2 intimates a similar function for 
the C1ORF112 protein.
Some FA proteins, including BRCA2 (FANCD1), are 
known to play an important role in the formation of chi-
asmata and meiotic segregation in mammalian cells [52]. 
A possible role for C1ORF112 in meiosis has also been 
demonstrated in plants. There have been studies of plant 
homologues of C1ORF112, a homology that was inferred 
from the presence of the sequences in DUF4487, and these 
sequences contain the WCF tripeptide. One of these studies 
is of a novel rice (Oryza sativa) protein MEICA1, which 
contains the conserved WCF tripeptide and is present within 
the domain DUF4487. MEICA1 is suggested to interact 
with TOP3α and thereby regulate meiotic segregation [53]. 
This interaction enabled accurate meiotic segregation in the 
pachytene stage of wild‐type seeds. Mutant seeds, although 
showing normal vegetative growth, were mostly sterile due 
to an aberrant association of non‐homologous chromosomes 
[53]. Another study of the rockcress (Arabidopsis thali-
ana) protein AT1G04650 (also known as Holliday junction 
resolvase or FLIP) which similarly contains this conserved 
WCF tripeptide sequence and is present within the domain 
DUF4487 was identified via tandem affinity purification 
mass spectrometry as a meiotic crossover limiting factor 
[8]. AT1G04650 is reported to act in tandem alongside 
FIGL1 to limit meiotic crossover. Conversely, A. thaliana 
FANCD2 promotes meiotic crossover formation [54], hint-
ing at yet another functional link between C1ORF112 and 
the FA pathway.
Fig. 4  Potential protein–protein 
interactions with C1ORF112 
(centre) obtained through 
BioGRID [44]. Figure rendered 
using the GeneMANIA website 
[45]. Pink lines indicate possi-
ble physical interactions, while 
blue ones indicate co‐expression 
interactions
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Tissue expression and regulatory associations of C1ORF112
Due to the paucity of information relating to C1ORF112 
within the extant literature, we searched other online 
resources to gain insights into the regulation and pos-
sible functions of C1ORF112. One fluorescent antibody 
(obtained from the Protein Atlas (https ://www.prote inatl 
as.org/ENSG0 00000 00460 ‐C1orf 112/) suggests that 
C1ORF112 may co‐localise to the mitochondria, although 
this assertion needs to be further validated. Furthermore, 
the Protein Atlas showed that C1ORF112 is widely 
expressed in a number of cell types with no significant 
tissue specificity. Expression of the C1ORF112 RNA has 
been detected in Karpas‐707 cell lines derived from lym-
phoid cells, and also in K‐562-derived from myeloid cells 
with a high level of RNA expression which is some 22-to-
25-fold higher than observed in other cell lines [55]. Cells 
with lymphoid and myeloid lineages, such as monocytes, 
basophils, and natural killer cells, exhibit higher levels 
of expression of C1ORF112 RNA, which are > fourfold 
higher than measured in other cells [55]. C1ORF112 is 
also expressed in many tissues. However, it is should 
be noted that it exhibits a very high expression in endo-
crine tissues such as the testis and parathyroid gland, as 
well as in primary lymphoid organs like the thymus [56]. 
These results align with other data, including that of the 
BioGPS [57], which indicates that the testis has a higher 
level of expression of C1ORF112 as compared to other 
organs (http://biogp s.org/#goto=gener eport &id=55732 ). 
Likewise, according to the GTEx portal [58], C1ORF112 
exhibits high levels of expression within the testis and also 
in Epstein–Barr virus‐transformed lymphocytes, although 
there is only a modest level of expression in the brain and 
a relatively low level of expression in most other cells and 
tissues within the body (Fig. 5).
ChIP‐seq data from the ENCODE database (Consortium 
2004) show elevated levels of active H3K27Ac marks pre-
sent within the promoter region of C1ORF112. Various cell 
lines, ranging from cancer to embryonic stem cells, exhibit 
higher chromatin accessibility which indicates that this gene 
is highly accessible to epigenetic acetylation marks. Further-
more, the ENCODE database reveals significant transcrip-
tion levels of C1ORF112 in several cell types according to 
RNA‐seq. The GM12828, H1‐hESC, HeLa‐S3, HepG2, and 
K562 cell lines show the highest levels of transcription of 
C1ORF112. Many regulatory regions tend to be DNase‐sen-
sitive, as the open chromatins are easily cleaved by DNase. 
The same phenomenon is observed within the promoter 
region of C1ORF112, suggesting that it has the open chro-
matin needed for its expression. C1ORF112 possesses a 
well‐conserved active promoter region that is featured across 
many different cell lines.
Finally, the GWAS catalogue [59] reveals potential asso-
ciations of C1ORF112 with amyotrophic lateral sclerosis, 
acne, epigenetic age acceleration, venous thromboembo-
lism, and blood protein levels (https ://www.ebi.ac.uk/gwas/
genes /C1orf 112), and these findings open further avenues 
for future studies.
Fig. 5  Relative levels of expression of C1ORF112 across various cell 
and tissue types within the body. C1ORF112 shows relatively higher 
levels of expression in the testis and in Epstein–Barr virus‐trans-
formed lymphocytes. Data obtained from the GTEx portal (https ://
gtexp ortal .org/home/gene/C1ORF 112)
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Potential relevance of C1ORF112 to cancer
Data from various databases such as BioGPS and GTEx 
reveal that C1ORF112 has a strong correlation with onco-
genesis through co-expression with genes previously related 
to cancer. C1ORF112 is highly expressed within both breast 
and cervical cancer. Furthermore, it is expressed at high lev-
els within the testis in both normal and cancerous cells. For 
example, C1ORF112 is generally overexpressed in neopla-
sia derived from various organs when compared to healthy 
tissues [60]. Similar results have been obtained from Gen-
evestigator data [36], which revealed high levels of expres-
sion of C1ORF112 across various tumours. A gain in copy 
number in C1ORF112 has also been observed in some types 
of cancers and, most significantly, in breast cancer [61, 62]. 
Furthermore, expression levels of C1ORF112 are correlated 
with survival in endometrial cancer, and patients with higher 
levels of expression of the gene also have a poorer progno-
sis (https ://www.prote inatl as.org/ENSG0 00000 00460 ‐C1orf 
112/patho logy). Therefore, further studies of the C1ORF112 
gene and its various protein forms are certainly warranted. 
C1ORF112 could also present a potential therapeutic target 
and serve as a diagnostic marker.
C1ORF112 is also linked with head and neck cancers, 
such as head and neck squamous cell carcinoma (HNSCC), 
according to Genevestigator [36], and it is significantly over-
expressed in both these forms of cancer [63]. Interestingly, 
HNSCC is extremely common in Fanconi anaemia patients 
[4]. Given that this susceptibility to HNSCC results from 
a defect in the FA pathway, it is tempting to speculate that 
overexpression of C1ORF112 leads to a dysregulation of 
the FA pathway which may, in turn, contribute to the devel-
opment of HNSCC in non‐FA individuals. Clearly, further 
investigations are required to confirm any definitive associa-
tion with either FA or HNSCC.
Conclusions
Given the expression patterns and identified interactions of 
C1ORF112, it could well be a DNA replication‐associated 
protein. If this theory is confirmed, it might be a useful can-
didate protein to study in the context of cell cycle regula-
tion, DNA damage responses, homologous recombination, 
maintenance of genome integrity, and, ultimately, cancer 
progression. C1ORF112 is potentially an FA‐associated 
gene, although it is highly conserved from an evolutionary 
standpoint, unlike most of the upstream FA genes. However, 
given its strong associations with both Fanconi anaemia 
and homologous recombination repair, and the observation 
that it is embryonically lethal (like BRCA1 and BRCA2), 
this places C1ORF112 in the downstream stretch of the 
FA pathway. The prevailing evidence indicates an intimate 
association with the cell cycle as well as the DNA repair 
of double‐strand breaks and stalled replications forks that 
are associated with inter‐strand crosslinks and chromosomal 
segregation. It might be hypothesised that C1ORF112 is a 
nuclear protein, one which is involved in the efficient cou-
pling and uncoupling of DNA strands during homologous 
recombination repair and chromosomal segregation in mei-
otic cells.
In summary, the evidence to date reveals that C1ORF112 
is essential for normal mammalian development and has 
important biological functions, as is evidenced from data 
obtained from both mice and mammalian cells. Still, there 
seems to be more in the way of questions than answers 
in relation to the function of C1ORF112. Clearly, much 
more work is needed to understand the potential roles of 
C1ORF112 in cell cycle regulation, maintaining genomic 
stability and normative DNA damage signalling path-
ways, not to mention a future exploration of its potential 
associations with oncogenesis. A deeper understanding of 
C1ORF112’s cellular mechanics is required to determine 
the nature of its intimate associations with the regulation of 
the cell cycle as well as in DNA replication and repair. This 
knowledge will ultimately determine whether its modulation 
might be beneficial in regulating cancer and its outcomes.
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